Evidence map›Paper›PMID 31125336›Full record

ArticlePloS one2019

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.

Michelle Rath, Qiyuan Li, Huili Li, Sara Lindström, Alexander Miron, Penelope Miron, Anne E Dowton, Meghan E Meyer, Bryce G Larson, Mark Pomerantz and 11 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01468246 (Helping Ourselves, Helping Others), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01468246 active not recruitingnot on this map

Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study

TypeobservationalSponsorDana-Farber Cancer InstituteRan2006 to 2035Enrolled1,302ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Update on the relationship between theThe Journal of international medical research · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Michelle RathDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.ORCID 0000-0002-1546-9405
Qiyuan LiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Huili LiNational Engineering Research Center for Biochip, Shanghai Biochip Limited Corporation, Shanghai, China.
Sara LindströmDepartment of Epidemiology, University of Washington, Seattle, United States of America.
Alexander MironDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States of America.
Penelope MironDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States of America.
Anne E DowtonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Meghan E MeyerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Bryce G LarsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Mark PomerantzDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.ORCID 0000-0003-4914-1157
Ji-Heui SeoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Laura C CollinsDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States of America.
Hilde VardehDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States of America.
Elena BrachtelDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, United States of America.
Steven E ComeBeth Israel Deaconess Medical Center, Boston, United States of America.
Virginia BorgesUniversity of Colorado Denver, Aurora, United States of America.
Lidia SchapiraStanford University Medical Center, Palo Alto, United States of America.
Rulla M TamimiDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America.
Ann H PartridgeDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Matthew FreedmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America.
Kathryn J RuddyDepartment of Oncology, Mayo Clinic, Rochester, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenome-wide-association studies (GWAS) have identified numerous single nucleotide polymorphisms (SNPs) that are associated with an increased risk of breast cancer. Most of these studies were conducted primarily in postmenopausal breast cancer patients. Therefore, we set out to assess whether or not these breast cancer variants are also associated with an elevated risk of breast cancer in young premenopausal patients.

methodsIn 451 women of European ancestry who had prospectively enrolled in a longitudinal cohort study for women diagnosed with breast cancer at or under age 40, we genotyped 44 SNPs that were previously associated with breast cancer risk. A control group was comprised of 1142 postmenopausal healthy women from the Nurses' Health Study (NHS). We assessed if the frequencies of the adequately genotyped SNPs differed significantly (p≤0.05) between the cohort of young breast cancer patients and postmenopausal controls, and then we corrected for multiple testing.

resultsGenotyping of the controls or cases was inadequate for comparisons between the groups for seven of the 44 SNPs. 9 of the remaining 37 were associated with breast cancer risk in young women with a p-value <0.05: rs10510102, rs1219648, rs13387042, rs1876206, rs2936870, rs2981579, rs3734805, rs3803662 and rs4973768. The directions of these associations were consistent with those in postmenopausal women. However, after correction for multiple testing (Benjamini Hochberg) none of the results remained statistically significant.

conclusionAfter correction for multiple testing, none of the alleles for postmenopausal breast cancer were clearly associated with risk of premenopausal breast cancer in this relatively small study.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAdultAllelesBreast NeoplasmsFemaleGenotypeHumansMiddle AgedPolymorphism, Single NucleotideReceptors, EstrogenRisk FactorsReceptors, Estrogen

Identifiers

PMID31125336
PMCPMC6534300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.